McLeod's syndrome
Neuroacanthocytosis
Neuroacanthocytosis is the general term for conditions that are associated with acanthosytosis (red blood cells with multiple thorny projections) and present with neurological symptoms such as chorea, neuropsychiatric symptoms, or dementia.
Neuroacanthocytosis can be divided into two groups: those that present with involuntary movements, such as chorea, and those that do not present with involuntary movements. Among the former core group, Chorea acanthocytosis (this article), McLeod's syndrome (this article), Huntington disease-like 2 (HDL2), and Pantothenate kinase-associated neurodegeneration (PKAN) are the most common neuroacanthocytosis.
McLeod's syndrome
McLeod's syndrome is typically characterized by its onset in individuals aged between 30 and 70 years, manifesting symptoms including chorea, psychiatric disturbances, and epilepsy. An elevated serum creatine kinase (CK) level is also observed, indicative of underlying myopathy and cardiomyopathy.
Atrophy
-
Caudate nucleus
In McLeod syndrome, MRI demonstrates atrophic changes involving the caudate nuclei.
Delete lesion
Do you really want to delete lesion Atrophy?
Putaminal hyperintensity
-
Putamen
T2WI and FLAIR shows hyperintensity involving lateral putamen.
Delete lesion
Do you really want to delete lesion Putaminal hyperintensity?